APYX

Apyx Medical Inc

APYX, USA

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

https://apyxmedical.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
APYX
stock
APYX

Apyx Medical Files Amendment with Delaware TipRanks

Read more →
APYX
stock
APYX

How AYON Momentum Is Rewriting the Growth Story for Apyx Medical Yahoo Finance

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$6

Analyst Picks

Strong Buy

1

Buy

0

Hold

2

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

27.79

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-33.93 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-3.46 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-31.49 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

8.77

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 41.13% of the total shares of Apyx Medical Inc

1.

Nantahala Capital Management, LLC

(8.8263%)

since

2025/06/30

2.

Archon Capital Management LLC

(8.6767%)

since

2025/06/30

3.

Royce & Associates, LP

(6.4509%)

since

2025/06/30

4.

Vanguard Group Inc

(3.9021%)

since

2025/06/30

6.

Commonwealth Equity Services Inc

(1.7545%)

since

2025/06/30

7.

Horizon Asset Management Inc/ny

(1.6261%)

since

2025/06/30

8.

BlackRock Inc

(1.3299%)

since

2025/06/30

9.

Taylor Frigon Capital Management LLC

(1.2663%)

since

2025/06/30

10.

Geode Capital Management, LLC

(0.9245%)

since

2025/06/30

11.

Private Advisor Group, LLC

(0.7664%)

since

2025/06/30

12.

Perkins Capital Management Inc

(0.6002%)

since

2025/06/30

13.

Kingsview Wealth Management, LLC

(0.5066%)

since

2025/06/30

14.

Renaissance Technologies Corp

(0.4796%)

since

2025/06/30

15.

Perceptive Advisors LLC

(0.3966%)

since

2025/06/30

16.

Northern Trust Corp

(0.315%)

since

2025/06/30

17.

State Street Corp

(0.289%)

since

2025/06/30

18.

Caption Management, LLC

(0.2848%)

since

2025/06/30

19.

Dimensional Fund Advisors, Inc.

(0.1991%)

since

2025/06/30

20.

Bridgeway Capital Management, LLC

(0.1629%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

No earnings data available.

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(2.5)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(3.8)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(2)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Low Quality Business(1.5)
Value
Overpriced(2)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.